What Helix TCS’ Merger with BioTrackTHC Means for Investors, Plus Exclusive CEO Video Interview
Ryan Allway
March 21st, 2018
Exclusive, News, Top News
Many investors look at the cannabis industry and see opportunities for cultivators (growers) and dispensaries (retailers). But, there are many other types of companies that are well positioned to profit from the industry’s substantial growth rates. Many of these companies also sidestep the risks assumed by growers and retailers that must touch the federally-illegal drug, which makes them a compelling addition to a well-rounded portfolio.
Helix TCS Inc. (OTCQB: HLIX) recently announced that it signed a merger agreement with Bio-Tech Medical Software Inc., dba BioTrackTHC, after acquiring a growing stake in the firm over the past several quarters. The move helps create one of the most promising pure play ancillary businesses in the burgeoning cannabis industry. Investors may want to take a closer look at the stock following the merger.
CFN Media recently sat down with Helix TCS CEO Zachary L. Venegas to discuss the company’s existing operations and plans for the future in an exclusive interview. The interview was conducted just prior to the Helix/BioTrackTHC merger announcement.
Ancillary Businesses
The cannabis industry is projected to reach $50 billion by 2026, according to Cowen & Co., driven by the legalization of adult-use and medical cannabis across a growing number of states. While many investors are focused on cultivators and dispensaries, ancillary businesses are poised to capture an even larger share of the market without the legal and financial risks that apply to working directly with the cannabis plant.
Helix TCS has focused on providing integrated operating environment solutions to the legal cannabis industry, including transportation, armed and unarmed guarding, training, investigation, and special services. At the same time, the company’s Cannabase is the oldest and largest wholesale platform in the industry, helping over 72 percent of all cannabis licensees in Colorado improve their sales and marketing efforts.
BioTrackTHC develops and licenses product traceability, inventory management, and point-of-sale software systems for the legal cannabis industry. With nine government contracts and over 2,200 installed systems, the company has become a leader in software systems that enable government regulators and licensed operators to track and capture data on cannabis from the point of inception through the product life cycle.
Potential Synergies
By leveraging its existing client base, the company has been rapidly growing its Cannabase operations, which provides proprietary insights into the industry. These insights are quickly becoming a key asset in the highly competitive market where cultivators and dispensaries are willing to pay for an edge.
“The synergies between Cannabase and BioTrack are significant and we will use them as a starting point for an industry defining platform,” said Helix TCS CEO Zachary L. Venegas in the press release announcing the merger. “The combined firm’s increased scope, linked with our focus on execution, will continue to set the standard for M&A in the industry. We are confident that this merger will enable the combined companies to accelerate growth.”
Cannabase can provide real-time market insights to wholesale growers and retailers, which helps them anticipate market trends, price changes, and volume fluctuations in both the adult-use and medical markets. In addition, the platform provides analytics to advertisers that are looking to market to growers and dispensaries, which helps them optimize their product and service offerings to match what these companies – and consumer demand – requires.
Looking Ahead
Helix TCS Inc. (OTCQB: HLIX) represents a compelling investment opportunity in the burgeoning cannabis industry. After its BioTrackTHC merger, the company has become perhaps the largest ancillary products and services provider, while setting the stage to capture unmatched data fields across the cannabis value chain. The latter development is important to companies who value the ability to use data and analytics to improve their business operations and predictive analytics.
For more information, visit the company’s website at www.helixtcs.com.
Disclaimer
The above article is sponsored content. Emerging Growth LLC, which owns CannabisFN.com and CFN Media, has been hired to create awareness. Please follow the link below to view our full disclosure outlining our compensation: https://cannabisfn.com/legal-disclaimer/
This article was published by CFN Enterprises Inc. (OTCQB: CNFN), owner and operator of CFN Media, the industry’s leading agency and digital financial media network dedicated to the burgeoning CBD and legal cannabis industries. Call +1 (833) 420-CNFN for more information.
About Ryan Allway
Mr. Allway has over a decade of experience in the financial markets as both a private investor and financial journalist. He has been actively involved in the cannabis industry since its inception, covering public and private companies.
Search CannabisFN
Press Coverage
Psychedelics Index
Top Videos
Tim has over 22 years of investment experience as a portfolio manager, asset allocator, and capital markets professional across multiple asset classes, geographies, and platforms. Tim has built and operated two hedge funds, a broker dealer, and raised over $1Bn in capital for his combined businesses. Tim remains a recognized voice within the investment community […]
Matt Hawkins is the founder and managing principal of Cresco Capital Partners, LLC (“Cresco”), a private equity firm focused specifically on investing in the legalized cannabis industry. Since its inception in the summer of 2015, Cresco has made 14 investments out of its first fund and is currently raising this fund, Fund II. Prior to the […]
Matthew (Matt) Karnes has over 20 years of diverse finance and accounting experience. Prior to founding GreenWave Advisors LLC, Matt worked in equity research focusing on the Radio Broadcasting and Cable Television industries for First Union Securities.
HempFusion is a leading health and wellness CBD company utilizing the power of whole-food hemp nutrition.
Network Partners
About CFN Media Group
CFN Enterprises Inc. (OTCQB: CNFN) owns and operates CFN Media Group, the premier agency and financial media network reaching executives, entrepreneurs and consumers worldwide. Through its proprietary content creation, video library, and distribution via www.CannabisFN.com, CFN has built an extensive database of cannabis interest, assisting many of the world’s largest cannabis firms and CBD brands to build awareness and thrive. For more information, please visit www.cfnenterprisesinc.com.
Disclaimer: Matters discussed on this website contain forward-looking statements that are subject to certain risks and uncertainties that could cause actual results to differ materially from any future results, performance or achievements expressed or implied by such statements. CFN Media Group, which owns CannabisFN, is not registered with any financial or securities regulatory authority and does not provide nor claims to provide investment advice or recommendations to readers of this release. CFN Media Group, which owns CannabisFN, may from time-to-time have a position in the securities mentioned herein and will increase or decrease such positions without notice. The Information contains forward-looking statements, i.e. statements or discussions that constitute predictions, expectations, beliefs, plans, estimates, or projections as indicated by such words as "expects", "will", "anticipates", and "estimates"; therefore, you should proceed with extreme caution in relying upon such statements and conduct a full investigation of the Information and the Profiled Issuer as well as any such forward-looking statements. Any forward looking statements we make in the Information are limited to the time period in which they are made, and we do not undertake to update forward looking statements that may change at any time; The Information is presented only as a brief "snapshot" of the Profiled Issuer and should only be used, at most, and if at all, as a starting point for you to conduct a thorough investigation of the Profiled Issuer and its securities and to consult your financial, legal or other adviser(s) and avail yourself of the filings and information that may be accessed at www.sec.gov, www.pinksheets.com, www.otcmarkets.com or other electronic sources, including: (a) reviewing SEC periodic reports (Forms 10-Q and 10-K), reports of material events (Form 8-K), insider reports (Forms 3, 4, 5 and Schedule 13D); (b) reviewing Information and Disclosure Statements and unaudited financial reports filed with the Pink Sheets or www.otcmarkets.com; (c) obtaining and reviewing publicly available information contained in commonlyknown search engines such as Google; and (d) consulting investment guides at www.sec.gov and www.finra.com. You should always be cognizant that the Profiled Issuers may not be current in their reporting obligations with the SEC and OTCMarkets and/or have negative signs at www.otcmarkets.com (See section below titled "Risks Related to the Profiled Issuers, which provides additional information pertaining thereto). For making specific investment decisions, readers should seek their own advice and that of their own professional advisers. CFN Media Group, which owns CannabisFN, may be compensated for its Services in the form of cash-based and/or equity-based compensation in the companies it writes about, or a combination of the two. For full disclosure, please visit: https://www.cannabisfn.com/legal-disclaimer/. A short time after we acquire the securities of the foregoing company, we may publish the (favorable) information about the issuer referenced above advising others, including you, to purchase; and while doing so, we may sell the securities we acquired. In addition, a third-party shareholder compensating us may sell his or her shares of the issuer while we are publishing favorable information about the issuer. Except for the historical information presented herein, matters discussed in this article contain forward-looking statements that are subject to certain risks and uncertainties that could cause actual results to differ materially from any future results, performance or achievements expressed or implied by such statements. CFN Media Group, which owns CannabisFN, is not registered with any financial or securities regulatory authority, and does not provide nor claims to provide investment advice or recommendations to readers of this release. CFN Media Group, which owns CannabisFN, may from time to time have a position in the securities mentioned herein and will increase or decrease such positions without notice. For making specific investment decisions, readers should seek their own advice and that of their own professional advisers. CFN Media Group, which owns CannabisFN, may be compensated for its Services in the form of cash-based and/or equity- based compensation in the companies it writes about, or a combination of the two. For full disclosure please visit: https://www.cannabisfn.com/legal-disclaimer/.
Copyright © Accelerize Inc. · All Rights Reserved · Privacy Policy · Legal Disclaimer
